Welcome to our blog dedicated to Life Sciences. We report on EU and national regulatory, compliance, intellectual property and transactional developments in the sector. We focus on (bio)pharmaceuticals and medical technologies, and also cover food and beverages, cosmetics and other healthcare products.

Belgium – Covid-19 coronavirus: ban on at-home tests lifted

Tine Carmeliet

On 21 September 2020, the Federal Agency for Medicines and Health Products (FAMHP) announced that, as of 19 September 2020, the ban on the sale of Covid-19 at-home tests, which has been in place since March 2020, has been lifted. The at-home tests aim to detect antibodies against coronavirus SARS-CoV-2 without the intervention of a Read More

Final parts of new French anti-gift regulation published

Jeanne Fabre

The new French “anti-gift” regulation, supplemented and specified by the decree of 15 June 2020 and the “threshold” decrees of 7 August 2020, has been fully effective since 1 October 2020 (see our previous blog post French anti-gift regulation is now complete!). Further to these texts, the following new orders finalise the regulation and add Read More

French medical cannabis pilot: call for applications for suppliers launched today – responses required by 24 November

Eveline Van Keymeulen

Today, the French National Agency for Medicines and Health Products Safety (ANSM) has officially launched the call for applications (“appel à candidatures”) for medical cannabis suppliers to participate in the pilot programme that will be started by 31 March at the latest.  The call for applications follows the publication of the ministerial order providing the Read More

Belgium: Covid-19 coronavirus: measures to combat medicine shortages extended again

Veerle Pissierssens

Since April 2020, the Belgian government has taken measures to avoid medicine shortages during the Covid-19 pandemic. These measures have subsequently been revised and extended in duration four times. The measures have now been further extended until 28 October 2020 by a Federal Agency for Medicines and Health Products (FAMHP) decision dated 25 September 2020, Read More

France: Presentation of 2021 measures for innovative medicines

Jeanne Fabre

On 30 September 2020, the French government published a press release announcing the draft of the French Social Security Financing Bill (PLFSS) for 2021, which it presented as “one of the most singular exercises since the creation of the PLFSS in 1996”. One of the main points of the PLFSS for 2021 is a specific Read More